US20110223608A1 - Molecular detection and quantification of enterococci - Google Patents
Molecular detection and quantification of enterococci Download PDFInfo
- Publication number
- US20110223608A1 US20110223608A1 US13/089,146 US201113089146A US2011223608A1 US 20110223608 A1 US20110223608 A1 US 20110223608A1 US 201113089146 A US201113089146 A US 201113089146A US 2011223608 A1 US2011223608 A1 US 2011223608A1
- Authority
- US
- United States
- Prior art keywords
- enterococci
- nasba
- quantification
- primer
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Definitions
- This invention relates to rapid detection of an organism, specifically, this is a method for detecting and quantifying Enterococci (a human fecal indicator organism) from sea water.
- NASBA real-time nucleic acid sequence based amplification
- NASBA is able to amplify RNA in a DNA background, and thus, only viable targets will be detected. This is important for indicator monitoring because only recent pollution events will be detected and false positive amplifications of naked DNA present in the sample will be eliminated.
- Indicator bacteria are chosen because of their ability to survive longer than the pathogenic organisms in question and therefore only viable bacteria should be considered as part of a risk analysis.
- Enterococci is the USEPA approved indicator organism used to monitor for fecal pollution in saline waters.
- Current methods rely on membrane filtration and even though the direct enumeration of these microorganisms using membrane filtration and plating has been available for years, there continue to be outbreaks associated with fecal contamination.
- the problem is that there is a lag of at least 24-48 hours between when the sample is collected and when the data become available. Changes in the water quality and potential exposures during this delay lead to management decisions and public notifications that are often times moot.
- To improve management abilities there is a need for rapid detection and quantification of appropriate bacterial indicators in coastal waters and sediments to ensure the safety of these resources for their multiple users.
- the present NASBA based method addresses this issue by quantitatively amplifying the target RNA and providing results in less than one hour.
- the FIGURE shows sequences for primers and probe for NASBA amplification of Enterococci.
- NASBA primers and probes were designed based on homologous regions of the large subunit ribosomal RNA gene (The FIGURE). This region is highly conserved within all reported species of the Enterococcus genus (Haugland et al., 2005). Previous researchers (Frahm and Obst, 2003) used this region as the priming site for the development of a Taqman PCR assay for enterococci detection.
- the primers have been modified to best fit the NASBA amplification requirements and molecular beacon design criteria as well as minimize the cross hybridization to each other.
- This primer set has been tested against Enterococcus faecalis and E. faecium, and E. avium, as well as several other genera of Gram positive and Gram negative bacteria to determine the specificity of the assay and ensure that no cross reactivity occurs to non-target organisms. Data thus far indicate that the primer set is specific to the genus enterococci.
- the assay sensitivity has been evaluated using serially diluted RNA isolated from enterococci cells. It is also possible to include cell extract samples from individual species as well as mixtures of all of the enterococci species available. Because ribosomal RNA tends to have a complex secondary structure, the NASBA assay was initiated by a 65° C. denaturing step for 3 minutes prior to the 41° C. amplification step (60 to 90 minutes). This initial denaturation is required for some, but not all NASBA assays and its requirement for efficient amplification of enterococci still needs to be evaluated.
- Amplification inhibitors are often co-purified with natural environmental samples. These inhibitors have been encountered in coastal water filtrates (Casper et al., 2005b). However, this inhibition tends to occur in sample volumes greater than 200 ml. For enterococci samples, the sample volume will always be less than 100 ml (as used by the DOH). Also, an internal control (IC-NASBA protocol) is included that will be used to normalize the amplification results (Patterson et al., 2005). This approach will increase the precision of our quantification and reduce the amount of false negative results. Because the internal control molecule contains the same priming site as the target, the amplification reaction becomes competitive. Serial titrations of internal control RNA determine the optimal concentration to allow for consistent quantification of enterococci within the expected environmental concentrations (Patterson et al., 2005).
Abstract
A primer pair and probe for the large subunit ribosomal RNA gene of enterococci for use in a real-time nucleic acid sequence based amplification (NASBA) assay.
Description
- This application is a continuation of U.S. patent application Ser. No. 11/735,618, filed Apr. 16, 2007, which claims the benefit of U.S. Provisional Patent Application 60/744,850, filed Apr. 14, 2006, the contents of each of which are herein incorporated by reference.
- This invention was made with Government support under Grant No. 25000 172 00 awarded by the National Science Foundation. The government has certain rights in the invention.
- This invention relates to rapid detection of an organism, specifically, this is a method for detecting and quantifying Enterococci (a human fecal indicator organism) from sea water.
- The coastal ocean is an important economic and recreational resource that is constantly influenced by human activities. In 2003, there were more than 18,000 days of beach closings throughout the US due to high concentrations of fecal bacteria. This was an increase of more than 51% over the previous year. Health related management of recreational coastal sites is currently undertaken by monitoring fecal coliform and enterococci by membrane filtration. Elevated concentrations of enterococci in marine waters have been shown to have a strong correlation with illness (especially gastrointestinal disease) in exposed individuals therefore making enterococci the indicator organism of choice for saline waters. The problem with this type of standard indicator monitoring is that there is a lag of at least 24-48 hours between when the sample is collected and when the data become available. Changes in the water quality and potential exposures during this delay lead to management decisions and public notifications that are often times inaccurate. To improve our management abilities, a primer pair and probe have been adapted for the large subunit ribosomal RNA gene of enterococci for use in a real-time nucleic acid sequence based amplification (NASBA) assay. This region is highly conserved within all reported species of the Enterococcus genus. Using this assay, the equivalent of less than one enterococci colony forming unit (CFU) was detected from a spiked sea water sample (100 ml). Further, there is a negative linear relationship (R2=0.9484) between CFUs obtained by membrane filtration and time to positivity (TTP) readings obtained with the NASBA assay. Therefore, quantitative estimates of enterococci are possible over at least four orders of magnitude and all positive samples amplified within forty-three minutes. By coupling this real-time NASBA assay to the inventor's existing field RNA extraction procedure and portable NASBA detection device, this technology will provide a simple, rapid (<1 hr), convenient testing format for coastal sites and greatly improve the health risk assessment of these regions.
- Unlike polymerase chain reaction (PCR) based methods, NASBA is able to amplify RNA in a DNA background, and thus, only viable targets will be detected. This is important for indicator monitoring because only recent pollution events will be detected and false positive amplifications of naked DNA present in the sample will be eliminated. Indicator bacteria are chosen because of their ability to survive longer than the pathogenic organisms in question and therefore only viable bacteria should be considered as part of a risk analysis.
- This is a method for the detection and quantification of Enterococci. Enterococci is the USEPA approved indicator organism used to monitor for fecal pollution in saline waters. Current methods rely on membrane filtration and even though the direct enumeration of these microorganisms using membrane filtration and plating has been available for years, there continue to be outbreaks associated with fecal contamination. The problem is that there is a lag of at least 24-48 hours between when the sample is collected and when the data become available. Changes in the water quality and potential exposures during this delay lead to management decisions and public notifications that are often times moot. To improve management abilities, there is a need for rapid detection and quantification of appropriate bacterial indicators in coastal waters and sediments to ensure the safety of these resources for their multiple users. The present NASBA based method addresses this issue by quantitatively amplifying the target RNA and providing results in less than one hour.
- For a fuller understanding of the invention, reference should be made to the following detailed description, taken in connection with the accompanying drawings, in which:
- The FIGURE shows sequences for primers and probe for NASBA amplification of Enterococci.
- NASBA primers and probes were designed based on homologous regions of the large subunit ribosomal RNA gene (The FIGURE). This region is highly conserved within all reported species of the Enterococcus genus (Haugland et al., 2005). Previous researchers (Frahm and Obst, 2003) used this region as the priming site for the development of a Taqman PCR assay for enterococci detection. The primers have been modified to best fit the NASBA amplification requirements and molecular beacon design criteria as well as minimize the cross hybridization to each other. This primer set has been tested against Enterococcus faecalis and E. faecium, and E. avium, as well as several other genera of Gram positive and Gram negative bacteria to determine the specificity of the assay and ensure that no cross reactivity occurs to non-target organisms. Data thus far indicate that the primer set is specific to the genus enterococci.
- The assay sensitivity has been evaluated using serially diluted RNA isolated from enterococci cells. It is also possible to include cell extract samples from individual species as well as mixtures of all of the enterococci species available. Because ribosomal RNA tends to have a complex secondary structure, the NASBA assay was initiated by a 65° C. denaturing step for 3 minutes prior to the 41° C. amplification step (60 to 90 minutes). This initial denaturation is required for some, but not all NASBA assays and its requirement for efficient amplification of enterococci still needs to be evaluated.
- Amplification inhibitors are often co-purified with natural environmental samples. These inhibitors have been encountered in coastal water filtrates (Casper et al., 2005b). However, this inhibition tends to occur in sample volumes greater than 200 ml. For enterococci samples, the sample volume will always be less than 100 ml (as used by the DOH). Also, an internal control (IC-NASBA protocol) is included that will be used to normalize the amplification results (Patterson et al., 2005). This approach will increase the precision of our quantification and reduce the amount of false negative results. Because the internal control molecule contains the same priming site as the target, the amplification reaction becomes competitive. Serial titrations of internal control RNA determine the optimal concentration to allow for consistent quantification of enterococci within the expected environmental concentrations (Patterson et al., 2005).
- The following citations are incorporated herein by reference:
- Haugland R. A., Siefring S. C., Wymer L. J., Brenner K. P., Dufour A. P. 2005. Comparison of Enterococcus measurements in freshwater at two recreational beaches by quantitative polymerase chain reaction and membrane filter culture analysis. Water Res.39(4):559-68.
- Frahm E, Obst U. 2003. Application of the fluorogenic probe technique (TaqMan PCR) to the detection of Enterococcus spp. And Escherichia coli in water samples. J Microb Meth 52: 123-131.
- It will be seen that the advantages set forth above, and those made apparent from the foregoing description, are efficiently attained and since certain changes may be made in the above construction without departing from the scope of the invention, it is intended that all matters contained in the foregoing description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.
- It is also to be understood that the following claims are intended to cover all of the generic and specific features of the invention herein described, and all statements of the scope of the invention which, as a matter of language, might be said to fall there between. Now that the invention has been described,
Claims (3)
1. A method for quantifying Enterococci in a sample of saline water, said method comprising: performing NASBA amplification, wherein said amplifying step comprises contacting said sample with a pair of primers to produce an amplification product, wherein said pair of primers comprises a first primer and a second primer, wherein said first primer comprises SEQ ID NO:1, and said second primer comprises SEQ ID NO: 2.
2. The method of claim 1 wherein said second primer includes a T7 promoter region comprising SEQ ID NO: 3.
3. The method of claim 1 further comprising a probe, said probe comprising SEQ ID NO: 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/089,146 US20110223608A1 (en) | 2006-04-14 | 2011-04-18 | Molecular detection and quantification of enterococci |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74485006P | 2006-04-14 | 2006-04-14 | |
US11/735,618 US7947441B2 (en) | 2006-04-14 | 2007-04-16 | Molecular detection and quantification of Enterococci |
US13/089,146 US20110223608A1 (en) | 2006-04-14 | 2011-04-18 | Molecular detection and quantification of enterococci |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/735,618 Continuation US7947441B2 (en) | 2006-04-14 | 2007-04-16 | Molecular detection and quantification of Enterococci |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110223608A1 true US20110223608A1 (en) | 2011-09-15 |
Family
ID=38610231
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/735,618 Expired - Fee Related US7947441B2 (en) | 2006-04-14 | 2007-04-16 | Molecular detection and quantification of Enterococci |
US13/089,146 Abandoned US20110223608A1 (en) | 2006-04-14 | 2011-04-18 | Molecular detection and quantification of enterococci |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/735,618 Expired - Fee Related US7947441B2 (en) | 2006-04-14 | 2007-04-16 | Molecular detection and quantification of Enterococci |
Country Status (2)
Country | Link |
---|---|
US (2) | US7947441B2 (en) |
WO (1) | WO2007120869A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2626481T3 (en) * | 2011-09-28 | 2017-07-25 | Lonza Walkersville, Inc. | Molecular targets and methods for formulation screening and preservative efficacy testing |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851330A (en) * | 1983-01-10 | 1989-07-25 | Kohne David E | Method for detection, identification and quantitation of non-viral organisms |
US5334501A (en) * | 1989-07-11 | 1994-08-02 | Microprobe Corporation | Quantification of bacteria using a nucleic acid hybridization assay |
US5409818A (en) * | 1988-02-24 | 1995-04-25 | Cangene Corporation | Nucleic acid amplification process |
US5650290A (en) * | 1994-04-01 | 1997-07-22 | Hach Company | Method & Medium for use in detecting E. coli and total coliforms |
US5695946A (en) * | 1991-02-14 | 1997-12-09 | Vicam, Lp | Assay method for detecting presence of bacteria |
US5723597A (en) * | 1983-01-10 | 1998-03-03 | Gen-Probe Incorporated | Ribosomal nucleic acid probes for detecting organisms or groups of organisms |
US6001564A (en) * | 1994-09-12 | 1999-12-14 | Infectio Diagnostic, Inc. | Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
US6355421B1 (en) * | 1997-10-27 | 2002-03-12 | Boston Probes, Inc. | Methods, kits and compositions pertaining to PNA molecular beacons |
US6583275B1 (en) * | 1997-07-02 | 2003-06-24 | Genome Therapeutics Corporation | Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics |
US6821770B1 (en) * | 1999-05-03 | 2004-11-23 | Gen-Probe Incorporated | Polynucleotide matrix-based method of identifying microorganisms |
US7025112B1 (en) * | 2004-12-15 | 2006-04-11 | The United States Of America As Represented By The Secretary Of The Navy | Pretreatment processing of metal-matrix carbide power for mold casting of products |
US7118870B2 (en) * | 2001-09-28 | 2006-10-10 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Detection of fecal contamination using nucleic acid molecules that recognize bacterial 16S rDNA sequences |
US7422857B2 (en) * | 2005-10-28 | 2008-09-09 | University Of South Florida | Detection of polyketide synthetase gene expression in Karenia brevis |
US7563577B2 (en) * | 2001-06-27 | 2009-07-21 | University Of South Florida | Materials and methods for detection of enterovirus and norovirus |
US7700278B1 (en) * | 2003-01-08 | 2010-04-20 | University Of South Florida | Detection of red tide organisms by nucleic acid amplification |
-
2007
- 2007-04-16 WO PCT/US2007/009235 patent/WO2007120869A2/en active Application Filing
- 2007-04-16 US US11/735,618 patent/US7947441B2/en not_active Expired - Fee Related
-
2011
- 2011-04-18 US US13/089,146 patent/US20110223608A1/en not_active Abandoned
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851330A (en) * | 1983-01-10 | 1989-07-25 | Kohne David E | Method for detection, identification and quantitation of non-viral organisms |
US5723597A (en) * | 1983-01-10 | 1998-03-03 | Gen-Probe Incorporated | Ribosomal nucleic acid probes for detecting organisms or groups of organisms |
US5409818A (en) * | 1988-02-24 | 1995-04-25 | Cangene Corporation | Nucleic acid amplification process |
US5334501A (en) * | 1989-07-11 | 1994-08-02 | Microprobe Corporation | Quantification of bacteria using a nucleic acid hybridization assay |
US5695946A (en) * | 1991-02-14 | 1997-12-09 | Vicam, Lp | Assay method for detecting presence of bacteria |
US5650290A (en) * | 1994-04-01 | 1997-07-22 | Hach Company | Method & Medium for use in detecting E. coli and total coliforms |
US6001564A (en) * | 1994-09-12 | 1999-12-14 | Infectio Diagnostic, Inc. | Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
US6583275B1 (en) * | 1997-07-02 | 2003-06-24 | Genome Therapeutics Corporation | Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics |
US6355421B1 (en) * | 1997-10-27 | 2002-03-12 | Boston Probes, Inc. | Methods, kits and compositions pertaining to PNA molecular beacons |
US6821770B1 (en) * | 1999-05-03 | 2004-11-23 | Gen-Probe Incorporated | Polynucleotide matrix-based method of identifying microorganisms |
US7563577B2 (en) * | 2001-06-27 | 2009-07-21 | University Of South Florida | Materials and methods for detection of enterovirus and norovirus |
US7118870B2 (en) * | 2001-09-28 | 2006-10-10 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Detection of fecal contamination using nucleic acid molecules that recognize bacterial 16S rDNA sequences |
US7700278B1 (en) * | 2003-01-08 | 2010-04-20 | University Of South Florida | Detection of red tide organisms by nucleic acid amplification |
US7025112B1 (en) * | 2004-12-15 | 2006-04-11 | The United States Of America As Represented By The Secretary Of The Navy | Pretreatment processing of metal-matrix carbide power for mold casting of products |
US7422857B2 (en) * | 2005-10-28 | 2008-09-09 | University Of South Florida | Detection of polyketide synthetase gene expression in Karenia brevis |
US7888031B2 (en) * | 2005-10-28 | 2011-02-15 | University Of South Florida | Detection of polyketide synthetase gene expression in Karenia brevis |
Also Published As
Publication number | Publication date |
---|---|
WO2007120869A3 (en) | 2008-01-03 |
WO2007120869A2 (en) | 2007-10-25 |
US20070243550A1 (en) | 2007-10-18 |
US7947441B2 (en) | 2011-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
D'Aoust et al. | Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence | |
Siefring et al. | Improved real-time PCR assays for the detection of fecal indicator bacteria in surface waters with different instrument and reagent systems | |
Haugland et al. | Comparison of Enterococcus measurements in freshwater at two recreational beaches by quantitative polymerase chain reaction and membrane filter culture analysis | |
Rajal et al. | Molecular quantitative analysis of human viruses in California stormwater | |
Stults et al. | Application of the 5′ fluorogenic exonuclease assay (TaqMan) for quantitative ribosomal DNA and rRNA analysis in sediments | |
Pitkänen | Review of Campylobacter spp. in drinking and environmental waters | |
Silva et al. | On the track for an efficient detection of Escherichia coli in water: A review on PCR-based methods | |
Ishii et al. | Cladophora (Chlorophyta) spp. harbor human bacterial pathogens in nearshore water of Lake Michigan | |
Price et al. | E. coli as an indicator of contamination and health risk in environmental waters | |
Noble et al. | Comparison of rapid quantitative PCR-based and conventional culture-based methods for enumeration of Enterococcus spp. and Escherichia coli in recreational waters | |
Gensberger et al. | Evaluation of quantitative PCR combined with PMA treatment for molecular assessment of microbial water quality | |
Johnston et al. | A real‐time qPCR assay for the detection of the nifH gene of Methanobrevibacter smithii, a potential indicator of sewage pollution | |
Amberg et al. | Improving efficiency and reliability of environmental DNA analysis for silver carp | |
EP2010671B1 (en) | Detection and quantification of faecal pollution in an environmental sample | |
KR20070105980A (en) | Method of quantitatively analyzing microorganism targeting rrna | |
Henry et al. | Environmental monitoring of waterborne Campylobacter: evaluation of the Australian standard and a hybrid extraction-free MPN-PCR method | |
Gilbride | Molecular methods for the detection of waterborne pathogens | |
Satoh et al. | Simple and reliable enumeration of Escherichia coli concentrations in wastewater samples by measuring β-d-glucuronidase (GUS) activities via a microplate reader | |
Ahmed et al. | RT-qPCR and ATOPlex sequencing for the sensitive detection of SARS-CoV-2 RNA for wastewater surveillance | |
Maheux et al. | Abilities of the mCP agar method and CRENAME alpha toxin-specific real-time PCR assay to detect Clostridium perfringens spores in drinking water | |
US7888031B2 (en) | Detection of polyketide synthetase gene expression in Karenia brevis | |
US7947441B2 (en) | Molecular detection and quantification of Enterococci | |
EP3827096A1 (en) | Method for assessing fecal pollution in water | |
Fricker et al. | Use of the ISO 9308-1 procedure for the detection of E. coli in water utilizing two incubation temperatures and two confirmation procedures and comparison with defined substrate technology | |
Gillespie | Current status of molecular microbiological techniques for the analysis of drinking water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |